HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

UK BRCA mutation testing in patients with ovarian cancer.

Abstract
Despite the increasing clinical importance of germline BRCA mutation status in managing women with ovarian cancer, few patients are currently being tested. The traditional means of selecting patients for BRCA mutation testing using restrictive criteria will miss many women with a mutation. To expand access to testing and streamline the testing process, several centres in the UK have been developing new models for BRCA testing. Trials with these integrated models involving closer collaborations between genetics and oncology services are now under way. In addition to testing for BRCA mutations, there is also increasing interest in testing for other genes associated with a predisposition to ovarian cancer. Advances in next-generation sequencing technology have resulted in the development of comprehensive genetic testing panels for use in the research and diagnostic settings. Interest is also increasing in expanding testing for somatic mutations in ovarian cancer, particularly for genes such as BRCA1 and BRCA2, whereby mutations may allow more patients to benefit from targeted agents, including poly(ADP-ribose) polymerase inhibitors. In this review, the issues of who should be offered testing, how testing could be delivered, when testing should occur and the technology and costs associated with genetic testing are addressed.
AuthorsAngela George
JournalBritish journal of cancer (Br J Cancer) Vol. 113 Suppl 1 Pg. S17-21 (Dec 15 2015) ISSN: 1532-1827 [Electronic] England
PMID26669451 (Publication Type: Journal Article, Review)
Chemical References
  • Poly(ADP-ribose) Polymerase Inhibitors
Topics
  • Female
  • Humans
  • Mutation
  • Ovarian Neoplasms (drug therapy)
  • Poly(ADP-ribose) Polymerase Inhibitors (administration & dosage, metabolism, therapeutic use)
  • United Kingdom

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: